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ABSTRACT
Wepreviouslyshowedthatalcohol-preferring(P)ratshavehigherbonedensitythanalcohol-nonpreferring(NP)rats.Geneticmappingin
P and NP rats identified a major quantitative trait locus (QTL) between 4q22 and 4q34 for alcohol preference. At the same location,
several QTLs linked to bone density and structure were detected in Fischer 344 (F344) and Lewis (LEW) rats, suggesting that bone mass
and strength genes might cosegregate with genes that regulate alcohol preference. The aim of this study was to identify the genes
segregating for skeletal phenotypes in congenic P and NP rats. Transfer of the NP chromosome 4 QTL into the P background (P.NP)
significantly decreased areal bone mineral density (aBMD) and volumetric bone mineral density (vBMD) at several skeletal sites, whereas
transfer of the P chromosome 4 QTL into the NP background (NP.P) significantly increased bone mineral content (BMC) and aBMD in the
same skeletal sites. Microarray analysis from the femurs using Affymetrix Rat Genome arrays revealed 53 genes that were differentially
expressed among the rat strains with a false discovery rate (FDR) of less than 10%. Nine candidate genes were found to be strongly
correlated (r
2>0.50) with bone mass at multiple skeletal sites. The top three candidate genes, neuropeptide Y (Npy), a synuclein (Snca),
and sepiapterin reductase (Spr), were confirmed using real-time quantitative PCR (qPCR). Ingenuity pathway analysis revealed relation-
ships among the candidate genes related to bone metabolism involving b-estradiol, interferon-g, and a voltage-gated calcium channel.
We identified several candidate genes, including some novel genes on chromosome 4 segregating for skeletal phenotypes in reciprocal
congenic P and NP rats.  2010 American Society for Bone and Mineral Research.
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Introduction
O
steoporosis is a common multifactorial disorder character-
ized by reduced bone mass and microarchitectural
deterioration of bone tissue, leading to reduced bone strength
and increased susceptibility to fracture.
(1) Bone mineral density
(BMD), the most important surrogate for osteoporotic fracture, is
strongly heritable at every skeletal site.
(2,3) As much as 80% of
peak BMD and about a third of the variance in the risk of fracture
have been found to be attributable to genetic factors.
(3)
Although linkage studies in human and animal models have
identified many quantitative trait loci (QTLs) for different bone
phenotypes,
(4,5) the causal genes underlying these phenotypes
have yet to be discovered.
In a previous study we compared bone phenotypes in inbred
alcohol-preferring (P) and alcohol-nonpreferring (NP) rats.
(6)
These rat lines were developed at Indiana University for high and
low alcohol preference behavior by selective breeding from a
randomly bred closed colony of Wistar rats [Wrm: WRC (WI)BR
from Walter Reed Army Institute of Research, Washington, DC].
(7)
After selective breeding for 30 generations, inbreeding was
initiated and continued for another 20 generations to obtain
inbredPandNPlines.Usingtheseinbredlines,wedemonstrated
that P rats have significantly higher BMD than NP rats both in
long bones and in lumbar vertebrae.
(6) Furthermore, P rats have
larger cross-sectional area and stronger long bones than NP rats.
Using genome-wide linkage analysis, we identified several QTLs
on chromosomes 4, 5, 10, 12, and 16 influencing alcohol
ORIGINAL ARTICLE J JBMR
Received in original form August 17, 2009; revised form on October 28, 2009; accepted December 15, 2010. Published online January 29, 2010.
Address correspondence to: Charles H Turner, PhD, Department of Biomedical Engineering, Indiana University Purdue University Indianapolis (IUPUI), 1120 South
Drive, Fesler Hall 115, Indianapolis, IN 46202, USA. E-mail: turnerch@iupui.edu
Journal of Bone and Mineral Research, Vol. 25, No. 6, June 2010, pp 1314–1325
DOI: 10.1002/jbmr.8
 2010 American Society for Bone and Mineral Research
1314preference in P and NP rats.
(8) The major QTL for alcohol
preference was observed in the region between q22 and q34 on
chromosome 4, with an logarithms of odds (LOD) score of 9.2.
Interestingly,inaseparatelinkagestudyusinginbredFischer344
(F344) and Lewis (LEW) rats, several QTLs linked to bone density
and structure were identified at the same location,
(9,10)
suggesting that some novel bone mass–regulating genes might
have segregated during selective breeding for the alcohol-
preference trait.
Identification of candidate genes following the discovery of
QTLs for a complex disease such as osteoporosis requires
multiple approaches because the linkage region is usually broad
and harbors hundreds of genes. The development of a congenic
animalmodelthrough aseriesofbackcrossings isthefirst stepto
confirm a QTL and narrow down the QTL interval. By exploiting
this approach, we have created reciprocal congenic rats (P.NP
and NP.P) by introgressing the 4q22-q34 QTL region of one
inbred strain (donor) into the genetic background of another
inbred strain (recipient).
(11) In order to identify the effects of
transfer of the QTL on skeletal phenotypes, we measured
multiple bone phenotypes, including total BMD, bone mineral
content (BMC), total bone area, and biomechanical properties at
different skeletal sites in inbred and congenic P and NP rats.
Since body weight and activities might influence the bone
phenotypes, we compared the bone phenotypes in weight-
bearing (femur) versus non-weight-bearing (cranium) sites and
measured daily activity levels in these rats.
The purpose of this study is to identify genes segregating for
bone phenotypes in congenic P and NP rats. We performed
microarray-based gene expression analysis to identify the
candidate genes underlying the variations in skeletal pheno-
types in inbred and congenic P and NP rats. The differentially
expressed genes were ranked based on the proportion of the
variation in skeletal phenotypes explained by the expression
level of each gene. In addition, we used a network-based
pathway analysis tool to identify the known functional
interrelationships among these candidate genes.
Materials and Methods
Animals
We used 16 inbred male P and NP rats and 16 congenic male rats
(n¼8 per strain) derived from inbred P and NP rats. Generation
of each reciprocal congenic rat line (P.NP and NP.P) involved
transfer of the 4q22-q34 QTL region (demarcated by the flanking
markers D4Mgh16 at 34 cM and D4Rat55 at 55.5 cM) from one
inbred strain (donor) into the genetic background of another
inbred strain (recipient), as described previously.
(11) All rats were
developed and maintained at Indiana University. Transfer of the
donor region was accomplished by first producing (P NP or
NP P) N1F1 offspring and then backcrossing an N1F1 rat to a
recipient rat to obtain N2F1 progeny. Ten generations of
backcrossing were performed, followed by an intercross
between N10 animals to produce homozygous N10F1 animals,
which resulted in the congenic strains. The nomenclature for
congenicstrainsliststherecipientstrainfirstandthedonorstrain
second. Therefore, NP.P has the QTL at 4q22-4q34 donated from
the P onto the NP background. Rats were individually housed in
polycarbonate cages in a vivarium maintained on a 12-hour
light/dark cycle on sterilized northern white pine shavings
bedding and provided standard rat chow (NIH-31 Mouse/Rat
Diet 7017, Harlan Teklad, Madison, WI, USA) and water ad libitum.
The procedures performed throughout the experiment followed
the guidelines of the Indiana University Animal Care and Use
Committee (IACUC).
Euthanasia and specimen collection
Rats were euthanized by cervical dislocation at 6 months of age,
and lower limbs and lumbar vertebrae (L1–L6) were dissected
out.Thelowerlimbsontherightsidewereimmediatelystoredat
–208C for biomechanical testing. The lower limbs on the left side
were stripped of the muscle and transferred to 70% ethyl alcohol
and stored at 48C for densitometry analyses.
DNA isolation and genotyping
Isolation of genomic DNA and genotyping of each rat were
accomplished as described previously.
(11)
Cage activity test
Rats were assessed for motor activity for 1 hour in a Digiscan
animal activity monitor (Model VMRXYZ TAO, AccuScan
Instruments, Columbus, OH, USA) with dimensions of
42 42 30cm during both light and dark cycles. There were
16 beams to detect horizontal or vertical movement. Beam
spacing for all sensors was 2.5cm. All walls of the activity
chambers were composed of clear acrylic sheet. Activity
chambers were connected to the VersaMax/Digiscan analyzer
(Model CDA-8, AccuScan Instruments) for relay of movement
data to the Digipro software system (Versadat Version 1.50,
AccuScan Instruments). Activity chambers were cleaned thor-
oughly between tests. The average activity was determined from
both horizontal and vertical movements during light and dark
cycles.
Dual energy X-ray absorptiometry (DXA)
Whole-body and whole-cranial BMC and areal BMD (aBMD) were
measured using a fan-beam Hologic QDR 4500A DXA machine
(Hologic, Bedford, MA, USA) equipped with Hologic Version
11.2:3 software and a 1.698-mm-diameter collimator, with line
spacing of 0.0311cm, point resolution of 0.0311cm, and
acquisition time of 149seconds. The machine was calibrated
dailywith ananthropomorphic spine phantom.After completion
of the scan, mutually exclusive region-of-interest (ROI) boxes
weredrawn around the whole body and the cranium from which
aBMD and BMC were obtained. BMC was normalized by body
weight (BW) to adjust for differences in body size among the rat
lines.
The left femur and lumbar vertebrae 1 to 6 (L1–L6) were
scannedusing DXA (PIXImus IIMouse Densitometer, LunarCorp.,
Madison, WI, USA) with ultrahigh resolution (0.18 0.18mm/
pixel). During scanning, dissected femurs were positioned with
the lateral surface of the diaphysis facing down on a platform
supplied by the manufacturer. After completion of the scan of
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bone from which BMC/BW measurements were obtained.
Peripheral quantitative computed tomography (pQCT)
The left femur, proximal ends of the left femurs, and the fifth
lumbar vertebra (L5) were placed in plastic tubes filled with 70%
ethyl alcohol and centered in the gantry of a Norland Stratec XCT
Research SAþ pQCT System (Stratec Electronics, Pforzheim,
Germany). Two cross-sectional levels were scanned for femur—
one at the midshaft and one at the distal femur. The distal slices
were scanned approximately 1mm below the growth plate. For
thefemoralneck,fiveconsecutivescansperpendiculartotheneck
axis were obtained 0.25mm apart starting at the base of the
femoral head and ending at the greater trochanter. The lumbar
vertebraewerescannedforasingleslicethroughthecaudocranial
centerofthevertebralbody.Asingletomographysliceof0.26-mm
thicknesswastakenatthecollimationof4 10
5counts/sandata
voxel size of 0.07mm. For each slice, the X-ray source was rotated
through180degreesofprojectionforoneblock.Theslicethrough
the femoral midshaft and neck included mainly cortical bone,
whereastheslicesfromdistalfemurandlumbarvertebraincluded
both cortical and trabecular bones. For each slice of femoral
midshaft, distal femur, and L5, total volumetric BMD (vBMD) was
obtained using XCT Research SAþ Software Version 5.40 (Stratec
Electronics). For the femoralneck,totalvBMDwas measured from
the average values of all five slices pQCT images. Density
thresholds of 500 and 900mg/cm
3 were used to identify
mineralized bone.
Biomechanical testing
Thefrozenrightfemurswerebroughttoroomtemperatureslowly
inasalinebath.Thefemursweretestedinthree-pointbendingby
positioning them on the lower supports of a three-point bending
fixture and applying load at the midpoint using a material testing
machine(AllianceRT/5,MTSSystemsCorp.,EdenPrairie,MN,USA).
The bones were held in place by a small (1-N) preload and then
loaded in monotonic axial compression until fracture at a
crosshead speed of 20mm/min. Load was applied midway
between two supports that were 20mm apart. After the long
bones were fractured, cortical thickness was measured at the
midshaft and 5mm distal and proximal to the midshaft using
digital calipers accurate to 0.01mm and with a precision of
þ0.005mm (Mitutoyo, Aurora, IL, USA). For femoral neck, the
proximal half of each femur was mounted vertically in a special
chuck that clamped the femoral shaft to the lower platen of the
same materials testing machine. Load was applied downward
onto the femoral head at a crosshead speed of 20mm/min until
the femoral neck fractured. Force and displacement measure-
ments were collected every 0.05 second. From the force versus
displacement curves, ultimate force ( Fu, in N) was calculated in
TestWorks Software Version 4.06 (Eden Prairie, MN).
RNA extraction and microarray measurements
Femurs from 4-week-old P, NP, NP.P, and P.NP animals were
harvested and immediately frozen in liquid nitrogen and stored
at  808C until required. RNA from the femurs was extracted
(n¼5 per strain) using Trizol (Invitrogen, Carlsbad, CA, USA),
followedbyfurtherpurificationusinganRNeasyMiniKit(Qiagen,
Inc., Valencia, CA, USA) according to manufacturer’s instructions.
RNA then was treated with a DNA-free kit (Ambion, Austin, TX,
USA) to remove any residual genomic DNA. The quality of RNA
was determined using a 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA, USA) and was quantified using a spectro-
photometer (NanoDrop, Wilmington, DE, USA). For microarray
analysis, 5mg of total RNA from each sample was processed
according to the standard protocols from Affymetrix (GeneChip
Expression Analysis Technical Manual, Affymetrix, Santa Clara, CA,
USA), and 10mg of cRNA from each sample was hybridized to a
separate Rat Genome 230 2.0 Array (P/N 511056, Affymetrix) for
17 hours at 458C with constant rotation. The GeneChip then was
washed and stained in the Affymetrix Fluidics Station 400
according to the standard protocol. Subsequently, each array
was scanned by the Agilent GeneChip Scanner 3000 (Agilent
Technologies). All procedures were carried out using a balanced
design. The Rat Genome 230 Array has 31,000 probe sets
representing 28,700 well-substantiated rat genes.
Quality control (QC) for RNA and Affymetrix data
Measurement of the ratio between signals from the 50 and 30
ends of the GAPDH and b-actin genes (30/50 ratios) and the RNA
degradation plots were used for determination of RNA quality.
Affymetrix data QC was done by determining the percentage of
present or detection calls and the scale factors between the
arrays. To ensure that the overall gene expression profiles in all
the samples in each experimental condition were correctly
correlated, principal-component analysis was conducted.
Microarray data analysis and informatics
The images from each array were analyzed using an Affymetrix
GeneChip Operating System (GCOS) with Version 1.2 software.
The .cel files were analyzed in the statistical programming
environment R
(12) with tools available from the Bioconductor
Project.
(13) The normalization and log2 transformation of all
expression data were done using the robust multichip average
(RMA) method
(14,15) implemented in the Bioconductor RMA.
Affymetrix data were used for mapping of all probe sets to their
chromosomal location. The identities of the probe sets were
confirmed by comparing the target mRNA sequences on the
Affymetrix Rat Genome 230 2.0 GeneChip with the National
Center for Biotechnology Information (NCBI) GenBank database
(www.ncbi.nlm.nih.gov/Genbank/). Only probe sets that were
reliably detected (called present by the detection call generated
by the Affymetrix Microarray Analysis Suite 5.0 algorithm) were
analyzed; this reduces false positives.
(16)
Culture of primary osteoblasts
Calvaria were harvested from newborn P, NP, NP.P, and P.NP
pups (n¼5 to 8 per strain); cleaned of all loosely adherent
fibrous tissue, periosteum, and dura mater; and minced. The
dissected calvaria then were digested sequentially for seven
times each for 15minutes with 0.5mg/mL of crude collagenase
P (Roche Molecular Biochemical, Indianapolis, IN, USA) in a
solution of 3mL of trypsin/EDTA at room temperature with
gentle rocking. The supernatant from the first digestion was
1316 Journal of Bone and Mineral Research ALAM ET AL.discarded, and from each subsequent digest (digests 2 to 7),
released cells were collected. The pooled solution from digests
2 to 7 then was filtered through a Nitex membrane (Millipore
Corp., Bedford, MA, USA), centrifuged, and resuspended in a
minimum essential medium (a-MEM) (Invitrogen). Cells were
placed in 75-cm
2 flasks and grown in a-MEM supplemented
with 10% fetal bovine serum (FBS) and antibiotics (100IU/mL of
penicillin, 100mg/mL of streptomycin) at 378Ci nah u m i d i f i e d
atmosphere of 5% CO2. Once cells reached about 80%
confluence, they were resuspended with 0.05% trypsin in
EDTA and plated onto 75-cm
2 flasks. First-passage primary
osteoblasts were used for subsequent RNA isolation.
Real-time PCR measurements
Top candidate genes from microarray data were verified using
real-time quantitative PCR (qPCR). Two micrograms of total RNA
(the same RNA used for Affymetrix analysis; n¼3) was reverse
transcribed using Superscript III reverse-transcription reagent for
first-strand cDNA synthesis (Invitrogen). All PCR reactions
contained the first-strand cDNA corresponding to 100ng of
totalRNA.TaqManpredevelopedprimers,FAM-dye-labeledMGB
probes, and universal mastermix (Applied Biosystems, Foster
City,CA,USA)wereusedtoquantitytherelativegeneexpression.
Rat GAPDH was used as an endogenous control. Real-time
detection of PCR products was performed using an ABI PRISM
7300 sequence detector (Applied Biosystems). Relative expres-
sion of mRNA was calculated based on a relative standard curve
and normalized to GAPDH. All real-time PCR analyses used
triplicates of each of three biologic samples.
Statistics
To detect significant differences for bone phenotypes among all
rat strains, one-way ANOVA analysis was performed, followed by
Fischer’s protected least-significance differences. The level of
significance was set at .05. For BW correction of BMC and polar
moment of inertia (Ip), rat strains were compared using ANOVA
with BW as a covariate. For microarray analysis, p values among
all strains were calculated by ANOVA using the package
Limma.
(17) For comparison of differentially expressed trans-
regulated genes, we used the Welch t test between the strains
(NP versus NP.P and P versus P.NP). Because our hypothesis was
that cis-regulated genes within the introgressed regions would
be differentially regulated, the 460 probe sets that mapped to
the introgressed chromosome 4 QTL region (and therefore were
potentially cis-regulated) were analyzed separately. False
discovery rate (FDR) was calculated by the method of Benjamini
and Hochberg.
(18) Probe sets were considered differentially
expressed if the FDR was less than 10%. The microarray data set
was submitted to the NCBI Gene Expression Omnibus (GEO)
Express Web portal (GEO Accession Number GSE 12066). For
each phenotype of interest (ie, whole-body, cranial, femur, and
L1–L6 BMC/BW; whole-body and cranial aBMD; femur midshaft,
distal femur, and L5 total vBMD; and femur and femoral neck
ultimate force), regression analysis was performed with the
average gene expression level for the strain as the dependent
variable and the phenotypic mean value in animals of that strain
as the independent variable. The proportion of variation
(r
2 value) in the phenotypic means explained by the variation
in gene expression was obtained using the statistical software
package StatView (Abacus Concepts, Inc., Berkeley, CA, USA).
Pathway analysis
The interactions among differentially expressed genes for each
bone phenotype were investigated using Ingenuity Pathway
Analysis (IPA 5.0, Ingenuity Systems, Inc., Mountain View, CA,
USA). Differentially expressed genes that explained a sig-
nificant proportion of the variation in bone phenotypes were
uploaded into the application. Each gene identifier was
mapped to its corresponding gene in the Ingenuity Pathway
Knowledge Base (IPKB). These genes were overlaid onto a
global network developed from the information contained in
the IPKB. Networks of these genes, defined as the reflection of
all interactions of a given gene defined in the literature, then
were generated algorithmically based on their connectivity.
The interactions indicate physical association, induction/
activation, or repression/inactivation of one gene product by
the other, directly or through another intermediary molecule.
Results
Effect of QTL transfer on body weight and cage activity
P rats had lower BWs and higher activity levels than NP rats
(Table 1). NP.P rats, containing the P 4q22-q34 QTL on the NP
background, had significantly lower BWs and increased activity
compared with NP rats. P.NP rats, with the NP QTL on the P
background, had significantly higher BWs but did not differ
significantly from the background P strain in activity level.
Effect of QTL transfer on bone mass
Whole-body and cranial aBMD and BMC measured
with DXA
P rats had significantly higher whole-body and cranial aBMD and
BMC/BW than NP rats (Table 2). NP.P rats had higher whole-body
and cranial aBMD and whole-body BMC/BW than NP rats,
demonstrating that the presence of the P QTL increased BMD
Table 1. Body weight and cage activities in NP, NP.P, P.NP and P rats (n¼8)
a
Phenotypes
Strains ANOVA p-value
NP NP.P P.NP P NP/P NP/NP.P P/P.NP NP.P/P.NP
Body Weight (g) 639 29 609 33 597 24 543 29 <0.0001 0.01 0.0002 0.47
Average activity 5126 1722 7290 2435 7849 1484 8194 972 0.001 0.02 0.7 0.54
aValues are mean standard deviation (SD).
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1320 Journal of Bone and Mineral Research ALAM ET AL.in NP rats. Conversely, P.NP rats had significantly lower whole-
body and cranial aBMD and BMC/BW than P rats, indicating that
the presence of the NP QTL lowered BMD.
It is noteworthy that we detected higher BMD in P rats than in
NP rats at a non-weight-bearing area such as the cranium, and
the presence of the NP QTL significantly reduced bone mass in
the cranium, suggesting that the skeletal phenotypic differences
in these rats could not be explained only by increasing physical
activity levels.
Whole-femur and L1–L6 aBMD and BMC measured
with DXA
P rats had a significantly higher whole-femur BMC/BW and L1–L6
aBMD and BMC/BW than NP rats (Table 2). NP.P rats had a higher
femur BMC/BW and L1–L6 BMC/BW than NP rats, indicating that
the presence of the P QTL increased bone mass. Conversely, the
presenceoftheNPQTLloweredbonemassbecauseP.NPratshad
significantly lower femur aBMD and L1–L6 BMC/BW than P rats.
Femur midshaft, distal femur, femoral neck, and L5 total
vBMD measured with pQCT
P rats had a significantly higher total vBMD at most skeletal sites
(i.e., femur midshaft, distal femur, and L5) compared with NP rats
(Table 2). An exception was found at the femoral neck, where
total vBMD was significantly lower in P rats than in NP rats. There
were no differences in total vBMD for any of these sites between
Fig. 1. Of nine candidate genes that were highly correlated (r
2>0.5) with
averageBMC(Table3),anetworkoffiveeligiblegenes(Snca,Spr,Npy,Arf5,
and Gpnmb) was shown in Ingenuity pathway analysis (IPA). Well-known
pathways related to bone metabolism are highlighted in green.
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theNPbackgrounddidnothavemucheffectonvBMD.However,
the presence of the NP QTL in the P background significantly
lowered total vBMD at all these sites.
Effect of QTL transfer on Ip and bone strength
P rats had significantly more robust and stronger bones than NP
rats, as evidenced by significantly higher femoral neck Ip/Body
Weight (BW) and significantly greater ultimate force at the femur
and femoral neck (UF) (Table 2). NP.P rats had a significantly
higher femur Ip/BW and UF than NP rats, demonstrating that the
P QTL improved bone structure and strength. P.NP rats had a
significantly lower femoral neck UF than P rats, indicating that
the transfer of the NP QTL lowered bone strength. However, no
significant differences for femur and femoral neck Ip/BW were
observed between P and P.NP rats.
Effect of QTL transfer on gene expression
Microarray analyses
The Affymetrix microarray analyses using RNA from femurs
showedthatatotalof53genes,residinginthechromosome4QTL
region,including41candidategenesand12predictedgenes,were
differentiallyexpressed(FDR<0.10)amongtheratstrains(Table3).
We used the term candidate gene to refer to the differentially
expressed known genes with a setting of FDR <0.10. In addition,
predicted genes are the genes indicated as ‘‘predicted’’ in NCBI
GenBank Database with the same setting. Regression analyses
were performed to assess the correlation between gene
expression and skeletal phenotypes. Genes with a strong
correlation (r
2>0.50) in at least one phenotype of interest are
indicated in bold in Table 3. These were prioritized based on the
strengthofcorrelationforaverageBMCderivedfromwhole-body,
cranium,andhindlimbBMC.Atotalofninecandidategeneswere
found to be strongly correlated with average BMC (Table 3).
Pathway analysis
The nine candidate genes that were highly correlated with bone
phenotypes at multiple skeletal sites were mapped to pathways
using Ingenuity. Among the nine candidate genes that were
highly correlated with bone phenotypes at multiple skeletal
sites, six genes (Snca, Spr, Npy, Arf5, Gpnmb, and Fkbp14) were
identifiedbyIngenuity pathwayfornetworkanalysis. Fkbp14 was
not linked to the molecules within the same pathways. The
remaining fivegenes that wereeligiblefor network analysis were
directlyorindirectlyconnectedtopathwaysrelatedtob-estradiol
(E2), interferon-g (IFNG), and voltage-gated calcium channel
(VGCC) (Fig. 1).
Real-time quantitative PCR (qPCR) analyses
qPCR analyses of the top three candidate genes in Table 3 using
RNAfromfemursconfirmedthestrongcorrelationbetweengene
expression and bone mass and strength phenotypes (Table 4).
The correlation coefficients for a-synuclein (Snca), sepiapterin
reductase(Spr),andneuropeptideY(Npy)betweenmicroarrayand
qPCR analyses were 0.87, 0.87, and 0.91, respectively, indicating
good agreement between the two methods. The whole-femur
RNA comes from a variety of different types of cells, and thus we
cannotbesurethatthegene-expressionchangesoriginatedfrom
bone cells. To address this problem, we cultured primary
osteoblasts from rat calvaria and performed qPCR analysis of
gene expression for the three candidate genes. We observed
similar correlations between gene expression and bone pheno-
types, suggesting that osteoblastic cells are the main regulators
for bone mass and strength in these rats.
Cis- and trans-regulated genes
The preceding analyses focused on cis-regulated genes, that is,
genes within the QTL region that were differentially expressed
(Table 3). We also evaluated trans-regulated genes by comparing
differentially expressed genes between inbred (NP and P) and
their corresponding congenic (NP.P and P.NP) rats. A total of
seven genes outside the QTL region (trans-) were differentially
expressed between NP and NP.P rats at FDRs of less than 10%
(Table 5). No trans-regulated genes were identified in the
comparison of P with P.NP rats.
Discussion
Our results demonstrated that transfer of the NP chromosome 4
QTL (q22–q34) onto the P background (P.NP) significantly
increased body weight but decreased BMD at several skeletal
sites. Conversely, transfer of the P chromosome 4 QTL onto the
NP background (NP.P) significantly decreased body weight but
increased bone density at the same skeletal sites, indicating that
the chromosome 4 QTL harbors a gene or genes that affect bone
mass and structure. In addition, we identified several candidate
Table 5. Trans-regulated genes between NP and NP.P rats with a false discovery rate (FDR) less than 10%
a
Gene symbol Gene name Fold change p-value FDR Rat genome location
Ptgfrn Prostaglandin F2 receptor negative regulator 1.47 0.00001 0.04 2q34
Ddx58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58  1.31 0.00001 0.03 5q22
Otub2 OTU domain, ubiquitin aldehyde binding 2 1.27 0.00001 0.04 6q32
DnaJ Hsp40 homolog, subfamily B, member 2 1.19 0.00001 0.03 9q33
Bnip3l BCL2/adenovirus E1B 19kDa-interacting protein 3-like 1.11 0.00005 0.08 15p12
F13a Coagulation factor XIIIa  1.36 0.00005 0.08 17p12
RT1-Db1 RT1 class II, locus Db1  1.52 0.00002 0.04 20p12
aP allele is high bone mass expressing genotype.
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QTL region, that are differentially expressed and strongly
correlated with skeletal phenotypes in congenic P and NP rats.
We also confirmed the top three candidate genes (Snca, Spr, and
Npy) by qPCR.
Recently,therehasbeenconsiderableinterestinalinkbetween
brain and bone. Several studies have shown that hormones
produced in the brain regulate bone mass through neuroendo-
crinepathways.
(23–25)Interestingly,twoofthetopcandidategenes
(Snca and Npy) identified in this study were found to be
differentially expressed not only in bone cells but also in brain
tissue,
(19,30–32) indicating a possible link between neuronal
signaling and skeletal regulation of bone mass in these rats. Snca
hasbeenshowntobeassociatedwithalcoholpreferenceinrats
(19)
and with craving in alcoholics,
(20,21) as well as with upregulation
matrix mineralization in the human osteosarcoma cell line.
(22)
Interestingly,Npyaffectsbodyweight,alcoholpreference,anxiety,
and bone mass and strength. The effect of Npy on BW regulation
was demonstrated by several studies in mice,
(26,27) with high
expressionofNpyresultinginincreasedBW.AnullmutationinNpy
increasedalcoholpreferenceinmice,
(28,29)andlowerlevelsofNpy
expression in discrete brain regions in P rats was associated with
higher alcohol consumption.
(30,31) Furthermore, there is an
association between the decreased level of neuropeptide Y and
increasedanxiety inP rats,
(33) andtransfer ofthe P chromosome4
QTLontotheNPbackgroundcausedincreasedanxietyinNP.Prats
compared with NP rats (unpublished data). Several studies have
demonstrated that neuropeptide Y regulates bone mass by an
apparent neuronal pathway.
(34,35) Mice with impaired Npy
signalinghadhighercorticalandtrabecularbonemassatdifferent
skeletalsites.
(36–38)Inhumans,acommonpolymorphisminleucine
7 to proline 7 in prepro-Npy gene (Leu7Pro7) was found to be
associatedwithalcoholdependence
(39,40)andhigherfemoralneck
BMD in postmenopausal women.
(41) In addition, neuropeptide Y–
receptor genes are associated with alcohol dependence and
withdrawal phenotypes.
(42) All these studies suggest that
neuropeptide Y falls within a common genetic pathway affecting
bone mass, body weight, anxiety, and alcohol preference.
It is well established that increased physical activity is
associated with decreased BW
(43) and higher bone mass in
humans.
(44) However, the effect of activity is mostly restricted to
weight-bearing skeletal sites,
(45) and non-weight-bearing sites
such as the cranium are not strongly affected. Consequently, the
variation in bone mass at the cranium is more likely to be related
to genetic factors rather than the biomechanical effects of
activity. We found that P rats were more active than NP rats, and
transfer of the P chromosome 4 onto the NP background made
NP.P rats more active than NP rats. In addition, we found that P
rats had higher BMD than NP rats at several different skeletal
sites, and transfer of the P chromosome 4 onto the NP
background decreased bone mass in NP.P rats at the same sites,
suggesting that activity level might influence the BMD in P, NP
and congenic rats. The correlation coefficients between activity
and whole-body aBMD, L1–L6 aBMD, femur midshaft total vBMD,
distal femur total vBMD, and L5 total vBMD were 0.97, 0.88, 0.61,
0.68, and 0.65, respectively. These results suggest that the
biomechanical effects of activity play some role in the regulation
of bone mass in these rats. We also looked at bone density in the
cranium to evaluate genetic influences that are independent of
weight bearing. We detected significantly higher BMD values in
the crania of P rats compared with NP rats, and transfer of the
QTL region in both directions (NP.P and P.NP) was associated
with significantly increased or decreased bone mass in the
cranium compared with the background strains (NP and P).
These findings suggest a direct genetic effect on bone density,
independent of the biomechanical effects caused by alterations
in activity levels.
Since the BWs of P, NP, and the congenic rats were
significantly different and negatively correlated with BMD at
different skeletal sites, we normalized some of the bone-mass
phenotypes by BW to allow comparisons among the strains. The
normalized phenotypes included several BMC measurements
(bone mass) and polar moment of inertia (bone size). While it is
quite reasonable to normalize measures of bone mass or size by
BW, we recognize that such normalization could bias our results
by creating composite phenotypes that do not represent true
bone traits. Therefore, we were careful to compare the
normalized BMC measurements with the vBMD measures taken
from pQCT. We found that the normalized values of BMC
correlated well with the vBMD values across different skeletal
sites, suggesting that the normalization method did not distort
these skeletal phenotypes.
Inthisstudyweusedyoung(4-week-old)ratsratherthan adult
rats (26 weeks old) in the gene-expression study because gene
expression is substantially suppressed in the mature skeletons in
adult rats. We targeted a rapid skeletal growth phase so that the
gene expression should reflect the accrual of bone toward peak
bone mass obtained at 26 weeks and for which we detected
QTLs. Among nine candidate genes that were highly correlated
with bone phenotypes at multiple skeletal sites, a genetic
network of five eligible genes (Snca, Spr, Npy, Arf5, and Gpnmb)
was associated with direct or indirect pathways controlling cell
morphology, cell proliferation, integrin signaling, cellular
organization, receptor signaling, molecular transport, and organ
development (Fig. 1). Genes in the canonical pathways (network
generated in the IPA and known pathways that were associated
with metabolism or signaling) were related to serotonin and
dopamine receptor signaling, protein kinase C inhibitor and
integrin-mediated signaling, folate biosynthesis, and arginine
and proline metabolism. When these genes were categorized
based on location or cellular components Snca, Spr, and Arf5
were located in cytoplasm, whereas Npy and Gpnmb were
located in the plasma membrane. Interestingly, we detected
several pathways directly or indirectly related to the candidate
genes we obtained from this study with the genes already
reported to be related to bone metabolism (highlighted in
green). Among them, the pathway related to b-estradiol (E2) has
been shown extensively to regulate bone density and turn-
over.
(46–48) Interferon-g inhibits osteoclastogenesis,
(49) and vol-
tage-gated calcium channel pathway is essential for chondrocyte
proliferation and differentiation
(50) and mediates mechanical
load–induced bone formation.
(51) Gremlin 1 interacts with
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase acti-
vation protein (YWHAZ) and acts as an antagonist of the bone
morphogenetic protein (BMP) pathway.
(52) Identifying the
molecular mechanism by which Npy regulates estrogen and
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pathway thus will be valuable for understanding the skeletal
homeostasis controlled by these genes. Also, further investiga-
tion of bone phenotypes in knockout or transgenic animal
models involving these genes will provide important insight for
their role in bone-mass regulation. Additionally, gene silencing
using siRNA or overexpression of these genes in cell culture
systems can be undertaken for functional characterization of
these genes.
In this study we prioritized candidate genes by analyzing the
microarray-based expression of genes underlying the QTLs at rat
4q22–q34andcorrelatingthemwithmultipleskeletalphenotypes.
In another study using the same method, we investigated the
genomic expression for skeletal traits at femoral neck in F344 and
LEW strains.
(53) Interestingly, we detected two genes, Spr and
glycoprotein(transmembrane)nmb(Gpnmb)thatweresignificantly
(r
(2)>0.50) correlated with skeletal phenotypes in both P/NP
congenics and F344/LEW rats. Ranking of the microarray-based
candidategenesisusuallyperformedbyanalyzingthemagnitude
of expression differences (fold differences) between different
strains. However, with complex traits such as osteoporosis, even
subtle changes in gene expression could be important, and
therefore, a larger expression difference might not necessarily
identify the best candidate genes. We believe that the correlation
between gene expression and physical traits provides stronger
evidence for the association between a gene and a trait.
Most of the genes we identified in this study were cis-acting,
but we also found some novel trans-regulated genes between
NP and NP.P rats. However, besides these trans-regulated genes,
some other potential trans-acting genes might be influencing
bone phenotypes in these rat strains because the bone
parameters were not consistently different between NP and
NP.P and between P and P.NP rats for both DXA and pQCT
measurements(Table2).Cis-actingpolymorphismsarelocatedat
or near the gene that exhibits altered expression levels. Trans-
acting regulation involves polymorphisms within the QTL region
that affect gene expression outside the QTL. Trans-acting genes
can provide unique information about the gene networks
influencing complex phenotypes.
(54) The role of these trans-
regulated genes in bone metabolism is yet to be discovered.
In conclusion, using P and NP congenic rats, we demonstrated
that several candidate genes, including some novel genes
located within rat 4q22–q34, are differentially expressed and
strongly correlated with bone density. Among these genes, Npy
is a likely common genetic modulator for bone density, body
weight, activity, and alcohol preference. However, our approach
has several limitations. Identification of candidate genes by
correlating differential gene expression with the various skeletal
phenotypes simply provides us with a list of potential candidate
genes for further prioritization. Moreover, gene-expression study
based on microarray analysis explains only transcriptional
regulation of genes and does not capture the effects of
alternative gene splicing, polymorphism in the coding region
affecting protein structure and function, or posttranslational
modification of proteins. Also, whether the same candidate
genes regulate skeletal phenotypes in female rats remains to be
determined because we studied only male rats in this study.
Further studies involvingthe molecular mechanism by whichthe
genes identified in this study regulating bone mass thus are
necessary for the development of drugs to prevent and treat
osteoporosis.
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